Collagen-Specific HSP47+ Myofibroblasts and CD163+ Macrophages Identify Profibrotic Phenotypes in Deceased Hearts

Andrii Puzyrenko1, Elizabeth R Jacobs2,3,4, Nathan Padilla3

  • 1Department of Pathology Medical College of Wisconsin Milwaukee WI.

Insights

COVID-19 infection can cause cardiac fibrosis. Researchers found a "profibrotic phenotype" in hearts, marked by myofibroblasts, M2 macrophages, and collagen, suggesting a mechanism for heart complications in survivors.

Area of Science:

  • Cardiovascular Pathology
  • Virology
  • Immunology

Background:

  • Cardiac fibrosis is a known complication of SARS-CoV-2 infections, potentially leading to arrhythmias in survivors.
  • Heat shock protein 47 (HSP47) is a key regulator of collagen synthesis and secretion, implicated in fibrotic processes.

Purpose of the Study:

  • To investigate the presence and molecular mechanisms of cardiac fibrosis in individuals infected with SARS-CoV-2.
  • To examine the role of HSP47 and macrophages in virus-associated cardiac fibrotic changes.

Main Methods:

  • Human autopsy heart tissues from SARS-CoV-2 infected individuals and controls were analyzed.
  • Immunofluorescence and immunohistochemistry were used to quantify HSP47+, CD163+ (macrophage marker), and collagen α1(I) positive cells.
  • Tissue analysis focused on identifying co-localization in "hot spots".

Main Results:

  • Approximately 40% of SARS-CoV-2 infected hearts exhibited "hot spots" with increased HSP47+ cells, CD163+ macrophages, and collagen α1(I) deposition.
  • HSP47+ cells were identified as potential myofibroblasts, and CD163+ cells as M2 macrophages.
  • These profibrotic markers were found in close proximity within the "hot spots".

Conclusions:

  • The study presents the first evidence of a COVID-19-related "profibrotic phenotype" in human hearts, characterized by the in situ colocalization of myofibroblasts, M2 macrophages, and collagen.
  • These findings suggest a potential mechanism for viral-mediated cardiac fibrosis and highlight the need for further research into public health and diagnostic implications.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
17
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
21
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
25